2025 Seoul Consensus on Clinical Practice Guidelines for Irritable Bowel Syndrome
- Author:
Yonghoon CHOI
1
;
Young Hoon YOUN
;
Seung Joo KANG
;
Jeong Eun SHIN
;
Young Sin CHO
;
Yoon Suk JUNG
;
Seung Yong SHIN
;
Cheal Wung HUH
;
Yoo Jin LEE
;
Hoon Sup KOO
;
Kwangwoo NAM
;
Hong Sub LEE
;
Dong Hyun KIM
;
Ye Hyun PARK
;
Min Cheol KIM
;
Hyo Yeop SONG
;
Sung-Hoon YOON
;
Sang Yeol LEE
;
Miyoung CHOI
;
Moo-In PARK
;
In-Kyung SUNG
;
Author Information
- Publication Type:Review
- From:Journal of Neurogastroenterology and Motility 2025;31(2):133-169
- CountryRepublic of Korea
- Language:English
- Abstract: Irritable bowel syndrome (IBS) is a chronic, disabling, and functional bowel disorder that significantly affects social functioning and reduces quality of life and increases social costs. The Korean Society of Neurogastroenterology and Motility published clinical practice guidelines on the management of IBS based on a systematic review of the literature in 2017, and planned to revise these guidelines in light of new evidence on the pathophysiology, diagnosis, and management of IBS. The current revised version of the guidelines is consistent with the previous version and targets adults diagnosed with or suspected of having IBS. These guidelines were developed using a combination of de novo and adaptation methods, with analyses of existing guidelines and discussions within the committee, leading to the identification of key clinical questions. Finally, the guidelines consisted of 22 recommendations, including 3 concerning the definition and risk factors of IBS, 4 regarding diagnostic modalities and strategies, 2 regarding general management, and 13 regarding medical treatment. For each statement, the advantages, disadvantages, and precautions were thoroughly detailed. The modified Delphi method was used to achieve expert consensus to adopt the core recommendations of the guidelines. These guidelines serve as a reference for clinicians (including primary care physicians, general healthcare providers, medical students, residents, and other healthcare professionals) and patients, helping them to make informed decisions regarding IBS management.
